Invitation from EASL: Participate in a research study to facilitate optimal care in NAFLD, NASH and advanced fibrosis.
EASL is inviting you to participate in a study on optimal care in NAFLD, NASH and advanced fibrosis. EASL partnered with AXDEV who will help with the delivery of the project. The…
ILC 2021 – Second call for abstracts is now open!
Launching the second round of abstracts for ILC 2021: regular and high-profile, late-breaker abstracts
Launching Liver Matters: Voices and views from our community
By launching Liver Matters, EASL aims to serve the community in a fresh and different way, not structured by scientific tracks or fields of expertise. We’ll be offering you content focused on career and lifestyle, tips and tricks for making it in hepatology, profiles of…
Launching Digital NAFLD Summit 2021
EASL is delighted to announce Digital NAFLD Summit 2021, taking place online 16–17 September 2021. The pandemic has disrupted medical associations, but we’re in full force holding engaging, interactive online events keeping the hepatology community both connected and…
Multidisciplinarity – what horizons will this approach open up?
Multidisciplinary approaches to the health sciences are increasingly in demand – calling on multiple disciplines to tackle diseases from bench to bedside, from R&D through to patient care, often in multidisciplinary tumour boards or centres of…
Call for regular and high-profile, late-breaker abstracts for ILC 2021
EASL is pleased to announce the second round of abstract submissions for ILC 2021. We are calling for companies, scientists, researchers, and investigators to submit regular and high-profile, late-breaker abstracts, 10–27 April…
A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope
About EASL and the A-TANGO Consortium The A-TANGO Consortium, a five-year project, consists of 14 institutions across eight countries in Europe. It aims to perform Phase II clinical studies of an innovative…